Quick Answer
Probiotics Blood Pressure Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Gut microbiota, a new approach to management of polycystic ovary syndrome: a systematic review, meta-analysis and meta-evidence of 26 randomized controlled trials.
Key Takeaways
- 01Gut microbiota, a new approach to management of polycystic ovary syndrome: a systematic review, meta-analysis and meta-evidence of 26 randomized controlled trials. [Yin T (2026)]
- 02Trial sequential analysis confirmed that the evidence for LDL-C and insulin was sufficient to reach firm conclusions. [Zhong Y (2026)]
- 03Conclusion Probiotics have been shown to significantly reduce LDL-C and insulin levels in patients with CHD without increasing the risk of adverse events. [Zhong Y (2026)]
- 04Objective This study aims to investigate the effects of probiotic supplementation on blood glucose, lipids and pressure in patients with coronary heart disease (CHD) through systematic review and meta-analysis, combined with sequential trial analysis, and to assess its safety. [Zhong Y (2026)]
The current Migaku evidence database contains 2 reusable source documents for Probiotics Blood Pressure Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Gut microbiota, a new approach to management of polycystic ovary syndrome: a systematic review, meta-analysis and meta-evidence of 26 randomized controlled trials. [Yin T (2026); evidence level 1]
- Trial sequential analysis confirmed that the evidence for LDL-C and insulin was sufficient to reach firm conclusions. [Zhong Y (2026); evidence level 1]
- Conclusion Probiotics have been shown to significantly reduce LDL-C and insulin levels in patients with CHD without increasing the risk of adverse events. [Zhong Y (2026); evidence level 1]
- Objective This study aims to investigate the effects of probiotic supplementation on blood glucose, lipids and pressure in patients with coronary heart disease (CHD) through systematic review and meta-analysis, combined with sequential trial analysis, and to assess its safety. [Zhong Y (2026); evidence level 1]
- Methods A systematic search was conducted across five English-language databases: PubMed, Embase, Cochrane Library, Web of Science, and MEDLINE. [Zhong Y (2026); evidence level 1]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Gut microbiota, a new approach to management of polycystic ovary syndrome: a systematic review, meta-analysis and meta-evidence of 26 randomized controlled trials.
- Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis.